At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 605 enrolled
Drug / intervention
axillary lymph node dissection +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
In Brief
A Phase 3 clinical trial evaluating axillary lymph node dissection and whole breast irradiation for Breast Cancer. Completed, enrolled 605 participants across 156 sites in 4 countries.
Detailed Summary
RATIONALE: Surgery to remove lymph nodes in the armpit may remove cancer cells that have spread from tumors in the breast. PURPOSE: Randomized phase III trial to determine the effectiveness of removing lymph nodes in the armpit in treating women who have stage I or stage IIA breast cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesAustralia, Canada, Ireland, United States
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 3CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 1999
First PostedJan 2003
Primary CompletionAug 2007
Study CompletionFeb 2011
TodayJul 2026
First PostedJan 27, 2003
Enrollment StartApr 1, 1999
Primary CompletionAug 1, 2007
Study CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 23.4 years ago
Interventions
axillary lymph node dissectionprocedure
whole breast irradiationradiation